Clincosm LogoSign in Get a demo

Hypercoagulability

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Disease, Surgery-Complications, Hypercoagulability Trial in London (Redesca (enoxaparin sodium for injection), Fragmin

Not yet recruiting
  • Hepatic Disease
  • +3 more
  • Redesca (enoxaparin sodium for injection)
  • Fragmin (dalteparin)
  • London, Ontario, Canada
    London Health Sciences Centre
Nov 22, 2023

Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)

Recruiting
  • Acute Respiratory Failure
  • +2 more
  • Liverpool, New South Wales, Australia
    Intensive Care Unit, Liverpool Hospital, South Western Sydney Lo
Sep 15, 2022

Anticoagulation, Atrial Fibrillation, Atrial Flutter Trial (Panel Management for Anticoagulation Therapy, Usual Care)

Withdrawn
  • Anticoagulation
  • +6 more
  • Panel Management for Anticoagulation Therapy
  • Usual Care
  • (no location specified)
Aug 2, 2022

Prophylactic and Therapeutic Anticoagulants in Egyptian COVID-19

Completed
  • Covid19
  • +2 more
  • Cairo, Please Select, Egypt
    Teachers Hospital
Jul 19, 2022

Hypercoagulability, Obesity Trial in Cairo (active acupuncture low level laser in addition to nasal laser irradiation, treadmill

Recruiting
  • Hypercoagulability
  • Obesity
  • active acupuncture low level laser in addition to nasal laser irradiation
  • treadmill exercise
  • Cairo, Egypt
    Physical Therapy
Jul 6, 2022

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO

Completed
  • COVID-19
  • Hypercoagulability
  • Low Molecular Weight Heparin
  • Padova, Italy
    Giuseppe Camporese
Mar 17, 2021

Ovarian Hyperstimulation Syndrome, Hypercoagulability Trial (COAGO)

Terminated
  • Ovarian Hyperstimulation Syndrome
  • Hypercoagulability
  • COAGO
  • (no location specified)
Oct 1, 2019

Detecting Hypercoagulability in Morbidly Obese and Non Obese

Completed
  • Pregnancy
  • +2 more
    • Abu Dhabi, United Arab Emirates
      Corniche Hospital
    Nov 7, 2018

    Contraception, Hypercoagulability Trial (1.5 mg estradiol and 2.5 mg nomegestrol acetate, 15 µg ethinylestradiol and 60 µg

    Terminated
    • Contraception
    • Hypercoagulability
    • 1.5 mg estradiol and 2.5 mg nomegestrol acetate
    • 15 µg ethinylestradiol and 60 µg gestodene
    • (no location specified)
    May 8, 2018

    Graft Patency, Coronary Artery Bypass Grafting Surgery, Hypercoagulability Trial in Copenhagen (Clopidogrel+acetylsalicylic

    Unknown status
    • Graft Patency
    • +3 more
    • Clopidogrel+acetylsalicylic acid
    • acetylsalicylic acid
    • Copenhagen, Kbh, Denmark
      Dep. of cardiothoracic surgery, Rigshospitalet
    Sep 23, 2013

    Reduced Dose of Enoxaparin on Outcomes of Treatment With

    Unknown status
    • Acute Coronary Syndrome
    • +3 more
      • Jerusalem, Israel
        Hadassah Medical Organization
      Jul 3, 2011